5-MeO-2,N,N-TMT

Jump to navigation Jump to search
5-MeO-2,N,N-TMT
File:5-MeO-2,N,N-TMT.svg
Gene therapy
Clinical data
Physiological data
Legal status
Pharmacokinetic data
Identifiers
CAS Number
PubChem Template:Abbreviation
Chemical and physical data
FormulaC14H20N2O
Molar mass232.321 g/mol
3D model (JSmol)

5-MeO-2,N,N-trimethyltryptamine (5-MeO-2,N,N-TMT) is a tryptamine derivative that is a hallucinogenic drug. It was invented by Alexander Shulgin and reported in his book TiHKAL (#45) [1]. It is claimed to show psychoactive effects at a dosage of 75-150mg orally, but these are relatively mild compared to other similar drugs, suggesting that while the 2-methyl group has blocked the binding of metabolic enzymes, it is also interfering with binding to the 5HT2A receptor target that mediates the hallucinogenic effects of these drugs.


References

  1. ↑ http://www.erowid.org/library/books_online/tihkal/tihkal45.shtml

Template:TiHKAL Template:Hallucinogenic tryptamines Template:Hallucinogen-stub

Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=5-MeO-2,N,N-TMT&oldid=709208"